Additional booster doses in patients with chronic lymphocytic leukemia induce humoral and cellular immune responses to SARS‐CoV‐2 similar to natural infection regardless ongoing treatments: A study by ERIC, the European Research Initiative on CLL
American Journal of Hematology · 2024
DOI: 10.1002/ajh.27218 ↗Kurz gefasst
Leserbrief in der Zeitschrift American Journal of Hematology, 2024. Verfasst von A Campanella und 43 weiteren Autor:innen. Beteiligte Einrichtung: Vita Salute San Raffaele University, Milan, Italy. Hauptthemen laut MEDLINE: Leukemia, Lymphocytic, Chronic, B-Cell, COVID-19. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 13 Literaturangaben. Gefördert von: Janssen, MH CZ - DRO, Fondazione Umberto Veronesi.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Vita Salute San Raffaele University, Milan, Italy.
- IRCCS San Raffaele Hospital, Milan, Italy.
- Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
- Tel Aviv University, Tel-Aviv, Israel.
- Amsterdam UMC, Amsterdam, The Netherlands.
- Centre for Research and Technology Hellas, Thessaloniki, Greece.
ORCID-Profile: A Campanella, Y Herishanu, M Doubek, K Giannopoulos, S Alshemmari, S Levi, L Scarfò
Förderung
- Janssen
- MH CZ - DRO
- Fondazione Umberto Veronesi
Zitieren
APA
Campanella, A., Capasso, A., Heltai, S., Taccetti, C., Albi, E., Herishanu, Y., Haggenburg, S., Chatzikonstantinou, T., Doubek, M., Kättström, M., Giannopoulos, K., Simkovic, M., Moreno, C., Massaia, M., Bumbea, H., Alshemmari, S., Ranghetti, P., Perotta, E., Martini, F., …, & Ghia, P. (2024). Additional booster doses in patients with chronic lymphocytic leukemia induce humoral and cellular immune responses to SARS‐CoV‐2 similar to natural infection regardless ongoing treatments: A study by ERIC, the European Research Initiative on CLL. American Journal of Hematology. https://doi.org/10.1002/ajh.27218
Vancouver
Campanella A, Capasso A, Heltai S, Taccetti C, Albi E, Herishanu Y, et al. Additional booster doses in patients with chronic lymphocytic leukemia induce humoral and cellular immune responses to SARS‐CoV‐2 similar to natural infection regardless ongoing treatments: A study by ERIC, the European Research Initiative on CLL. American Journal of Hematology. 2024. doi:10.1002/ajh.27218
BibTeX
@article{Campanella2024,
author = {Campanella, A and Capasso, A and Heltai, S and Taccetti, C and Albi, E and Herishanu, Y and Haggenburg, S and Chatzikonstantinou, T and Doubek, M and Kättström, M and Giannopoulos, K and Simkovic, M and Moreno, C and Massaia, M and Bumbea, H and Alshemmari, S and Ranghetti, P and Perotta, E and Martini, F and Sant'Antonio, E and Colia, M and Combi, C and Levi, S and Kater, A P and Hazenberg, M and Nijhof, I S and Hofsink, Q and Demosthenous, C and Kotaskova, J and Zaleska, J and Vrbacky, F and Raya, A Mora and Bisogno, D and Tripoli, I E and Popov, V M and Roman, V and Stavroyianni, N and Karypidou, M and Scarano, E and Locatelli, M and Frenquelli, M and Scarfò, L and Stamatopoulos, K and Ghia, P},
title = {Additional booster doses in patients with chronic lymphocytic leukemia induce humoral and cellular immune responses to SARS‐CoV‐2 similar to natural infection regardless ongoing treatments: A study by ERIC, the European Research Initiative on CLL},
journal = {American Journal of Hematology},
year = {2024},
doi = {10.1002/ajh.27218}
}
EUVIMED